Horizon Pharma PLC | Ownership
Companies that own Horizon Pharma PLC
The Vanguard Group, Inc.
13,923,743
8.36%
452,080
0.01%
06/30/2018
BlackRock Fund Advisors
12,474,752
7.49%
357,916
0.01%
06/30/2018
Scopia Capital Management LP
11,912,290
7.15%
-3,251,063
4.32%
06/30/2018
William Blair Investment Management LLC
9,962,189
5.98%
628,727
0.39%
06/30/2018
Paulson & Co., Inc.
7,670,700
4.59%
0
3.05%
06/30/2018
Deerfield Management Company LP
6,609,894
3.97%
0
3.99%
06/30/2018
venBio Select Advisor LLC
5,593,683
3.36%
435,000
4.03%
06/30/2018
Dimensional Fund Advisors LP
5,419,571
3.25%
-700,106
0.03%
06/30/2018
Renaissance Technologies LLC
5,014,300
3.01%
1,695,700
0.11%
06/30/2018
SSgA Funds Management, Inc.
3,838,449
2.29%
64,156
0.01%
06/30/2018
| Address |
Connaught House
Dublin Dublin 4
Ireland
|
|
Employees
|
- |
| Website |
http://www.horizontherapeutics.com |
| Updated |
07/08/2019 |
| Horizon Pharma Plc engages in the research, development and market of pharmaceutical products. The medicines intend to treat arthritis, inflammation and orphan diseases. It distributes its products under the brands such as Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid, Ravicti, Rayos and Vimovo. |
